8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.01bn
- HK$386.14m
- CNY841.55m
- 74
- 93
- 81
- 98
Annual cashflow statement for Jilin Province Huinan Changlong Bio-pharmacy Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 175 | 150 | 177 | 197 | 198 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -14.8 | 56.7 | -0.685 | -4.84 | -1.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -49.3 | -77.6 | 9.62 | -22.1 | 91.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 133 | 151 | 215 | 204 | 316 |
| Capital Expenditures | -17 | -98.8 | -92.8 | -11.3 | -31.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -112 | -146 | -67.8 | -107 | 141 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -129 | -245 | -161 | -118 | 109 |
| Financing Cash Flow Items | 4.41 | 0.076 | 1.16 | 0.504 | 17.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -24.4 | -17.8 | -25.2 | -27.7 | -186 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21 | -111 | 29.3 | 58.3 | 239 |